微RNA-138抑制了乳腺癌细胞中缺氧诱导因子1α的表达

相关实验视频

Updated: Jun 21, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

Mohammad Fayyad-Kazan¹, Rim ElDirani², Michella Ghassibe-Sabbagh³

¹College of Arts and Sciences, Department of Natural and Applied Sciences, The American University of Iraq-Baghdad (AUIB), Baghdad, Iraq.

Nucleosides, nucleotides & nucleic acids

|July 15, 2024

概括

缺氧激活缺氧诱导因子1-α (HIF-1α),促进乳腺癌. 这项研究发现miR-138降低HIF-1α的调节,这表明它是抑制癌症转移的治疗标.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
基因法规基因法规

背景情况:

缺氧是癌症发展的关键因素,稳定缺氧诱导因子1-alpha (HIF-1α).
HIF-1α激活促进乳腺癌的进展,包括转移和治疗耐药性.
微RNA (miRNA) 是已知的癌症基因表达的调节者,包括瘤发生.

研究的目的:

研究miRNAs对乳腺癌细胞中HIF-1α表达的调节作用.
确定在低氧条件下放松调节的特定miRNA及其对HIF-1α的影响.
探索针对这些miRNA用于乳腺癌治疗的潜力.

主要方法:

在正常和缺氧条件下培养MCF-7和MDA-MB-231乳腺癌细胞.
使用TaqMan-低密度阵列 (TLDA) 描述miRNA表达特征.
验证miRNA-HIF-1α相互作用使用 luciferase 记者测定和lentiviral 转导.

主要成果:

缺氧使MCF-7细胞中的12个miRNA和MDA-MB-231细胞中的16个miRNA不受调节.
在低氧条件下,miR-138在两个细胞系中被发现是下调的.
miR-138直接与HIF-1α的3'UTR结合,并对其表达进行下调.

结论:

在低氧条件下,miR-138在调节HIF-1α表达方面发挥着重要作用.
降低miR-138的调节有助于稳定HIF-1α和潜在的乳腺癌进展.
向miR-138是一个有希望的治疗策略,可以减少HIF-1α,并抑制乳腺癌的侵袭和转移.

关键词:

乳腺癌是什么? 乳腺癌是什么这就是HIF-1α.缺氧缺氧是指缺氧的情况.这就是miRNAs.

更多相关视频

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization

Published on: June 7, 2016

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...